These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impaired metabolism of high density lipoprotein in uremic patients. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Kidney Int; 1992 Jun; 41(6):1653-61. PubMed ID: 1501422 [Abstract] [Full Text] [Related]
4. Evaluation of lipid and lipoprotein metabolism in rats as a model for studying age-related physiological changes. Lacko AG, Carlile S, Kudchodkar BJ. J Gerontol; 1984 Sep; 39(5):513-20. PubMed ID: 6470439 [Abstract] [Full Text] [Related]
17. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy. Kandasamy N, Ashokkumar N. Eur J Pharmacol; 2014 Nov 15; 743():53-62. PubMed ID: 25240712 [Abstract] [Full Text] [Related]
18. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients. Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H. Clin Nephrol; 1995 Apr 15; 43(4):268-77. PubMed ID: 7606882 [Abstract] [Full Text] [Related]
19. Abnormalities of carbohydrate and lipid metabolism in uremia. Bierman EL. Arch Intern Med; 1970 Nov 15; 126(5):790-2. PubMed ID: 5475702 [No Abstract] [Full Text] [Related]
20. [Progress of research on the properties and metabolism of high density lipoproteins]. Liu ZP, Wu BJ. Sheng Li Ke Xue Jin Zhan; 1987 Oct 15; 18(4):360-3. PubMed ID: 3330875 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]